100 related articles for article (PubMed ID: 23291154)
21. Dose-related effects of clozapine and risperidone on the pattern of brain regional serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
Batool F; Hasnat A; Haleem MA; Haleem DJ
Acta Pharm; 2010 Jun; 60(2):129-40. PubMed ID: 21134850
[TBL] [Abstract][Full Text] [Related]
22. Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.
Popova NK; Naumenko VS; Cybko AS; Bazovkina DV
Neuroscience; 2010 Aug; 169(1):229-35. PubMed ID: 20423722
[TBL] [Abstract][Full Text] [Related]
23. Alcohol administration during adulthood induces alterations of parvalbumin and glial fibrillary acidic protein immunoreactivity in rat hippocampus and cingulate cortex.
Vongvatcharanon U; Mukem S; Udomuksorn W; Kumarsit E; Vongvatcharanon S
Acta Histochem; 2010 Jul; 112(4):392-401. PubMed ID: 19446311
[TBL] [Abstract][Full Text] [Related]
24. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
25. Comparative behavioral changes in postpubertal rats after neonatal excitotoxic lesions of the ventral hippocampus and the prefrontal cortex.
Flores G; Silva-Gómez AB; Ibáñez O; Quirion R; Srivastava LK
Synapse; 2005 Jun; 56(3):147-53. PubMed ID: 15765522
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model.
Wang D; Noda Y; Zhou Y; Nitta A; Furukawa H; Nabeshima T
Neuropharmacology; 2007 Mar; 52(4):1179-87. PubMed ID: 17313962
[TBL] [Abstract][Full Text] [Related]
27. A comparative study of curcuminoids to measure their effect on inflammatory and apoptotic gene expression in an Aβ plus ibotenic acid-infused rat model of Alzheimer's disease.
Ahmed T; Gilani AH
Brain Res; 2011 Jul; 1400():1-18. PubMed ID: 21640982
[TBL] [Abstract][Full Text] [Related]
28. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated rats.
Kaalund SS; Riise J; Broberg BV; Fabricius K; Karlsen AS; Secher T; Plath N; Pakkenberg B
J Neurochem; 2013 Feb; 124(4):548-57. PubMed ID: 23083323
[TBL] [Abstract][Full Text] [Related]
30. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats.
Zuo J; Liu Z; Ouyang X; Liu H; Hao Y; Xu L; Lu XH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):387-97. PubMed ID: 17935847
[TBL] [Abstract][Full Text] [Related]
31. Prenatal exposure of Long-Evans rats to 17alpha-ethinylestradiol modifies neither latent inhibition nor prepulse inhibition of the startle reflex but elicits minor deficits in exploratory behavior.
Sandner G; Silva RC; Angst MJ; Knobloch J; Danion JM
Brain Res Dev Brain Res; 2004 Sep; 152(2):177-87. PubMed ID: 15351506
[TBL] [Abstract][Full Text] [Related]
32. Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats.
Schwabe K; Klein S; Koch M
Behav Brain Res; 2006 Mar; 168(1):150-60. PubMed ID: 16387372
[TBL] [Abstract][Full Text] [Related]
33. The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions.
Brzozowska NI; de Tonnerre EJ; Li KM; Wang XS; Boucher AA; Callaghan PD; Kuligowski M; Wong A; Arnold JC
Neuropsychopharmacology; 2017 Oct; 42(11):2222-2231. PubMed ID: 28272498
[TBL] [Abstract][Full Text] [Related]
34. Effects of neonatal lesions of the medial prefrontal cortex on adult rat behaviour.
Schwabe K; Enkel T; Klein S; Schütte M; Koch M
Behav Brain Res; 2004 Aug; 153(1):21-34. PubMed ID: 15219703
[TBL] [Abstract][Full Text] [Related]
35. Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia.
Chindo BA; Adzu B; Yahaya TA; Gamaniel KS
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):310-6. PubMed ID: 22561603
[TBL] [Abstract][Full Text] [Related]
36. Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice.
Ortega-Alvaro A; Aracil-Fernández A; García-Gutiérrez MS; Navarrete F; Manzanares J
Neuropsychopharmacology; 2011 Jun; 36(7):1489-504. PubMed ID: 21430651
[TBL] [Abstract][Full Text] [Related]
37. Risperidone-related weight gain: genetic and nongenetic predictors.
Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
[TBL] [Abstract][Full Text] [Related]
38. Neurobiological effects of neonatal maternal separation and post-weaning environmental enrichment.
Vivinetto AL; Suárez MM; Rivarola MA
Behav Brain Res; 2013 Mar; 240():110-8. PubMed ID: 23195113
[TBL] [Abstract][Full Text] [Related]
39. Impact of postnatal blockade of N-methyl-D-aspartate receptors on rat behavior: a search for a new developmental model of schizophrenia.
Wedzony K; Fijal K; Mackowiak M; Chocyk A; Zajaczkowski W
Neuroscience; 2008 Jun; 153(4):1370-9. PubMed ID: 18434025
[TBL] [Abstract][Full Text] [Related]
40. An animal model of schizophrenia based on chronic LSD administration: old idea, new results.
Marona-Lewicka D; Nichols CD; Nichols DE
Neuropharmacology; 2011 Sep; 61(3):503-12. PubMed ID: 21352832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
